Australian Capital Territory Numbered Acts

MEDICINES, POISONS AND THERAPEUTIC GOODS AMENDMENT ACT 2018 (NO. 23 OF 2018) - SECT 14

substitute

164     Information for CHO about monitored medicines supplied during consultations—Act, s 31 (2) (b) and (4), def required information

    (1)     This section applies if a prescriber supplies a monitored medicine for human use during a consultation.

Note     Supply does not include administer (see Act

, s 24).

    (2)     The prescriber must, not later than 7 days after the end of the month when the monitored medicine is supplied, give the chief health officer the following information in writing:

        (a)     the prescriber's name, business address and telephone number;

        (b)     the name, date of birth and address of the person to whom the medicine is supplied;

        (c)     the date of supply;

        (d)     the monitored medicine, and the form, strength and quantity of the medicine, supplied.